Cadila hits 52-week low on 14 observations from USFDA for Moraiya plant Posted By: Unknown May 06, 2019 Leave a Reply The US Food and Drug Administration has issued 14 observations after inspecting the drug firm's manufacturing facility at Moraiya in Ahmedabad. from Latest News http://bit.ly/2Vf2obE https://ift.tt/eA8V8J http://bit.ly/2SdCH5P Tweet Share Share Share Share
0 comments: